August 13, 2014Article
Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings
Aaron L. Berkowitz, M. Brandon Westover, Matt T. Bianchi, Sherry H-Y. Chou
First published August 13, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000779
Aaron L. Berkowitz
From the Department of Neurology (A.L.B., S.H.C.), Brigham and Women's Hospital, Harvard Medical School; and Department of Neurology (M.B.W., M.T.B.), Massachusetts General Hospital, Harvard Medical School, Boston.
M. Brandon Westover
From the Department of Neurology (A.L.B., S.H.C.), Brigham and Women's Hospital, Harvard Medical School; and Department of Neurology (M.B.W., M.T.B.), Massachusetts General Hospital, Harvard Medical School, Boston.
Matt T. Bianchi
From the Department of Neurology (A.L.B., S.H.C.), Brigham and Women's Hospital, Harvard Medical School; and Department of Neurology (M.B.W., M.T.B.), Massachusetts General Hospital, Harvard Medical School, Boston.
Sherry H-Y. Chou
From the Department of Neurology (A.L.B., S.H.C.), Brigham and Women's Hospital, Harvard Medical School; and Department of Neurology (M.B.W., M.T.B.), Massachusetts General Hospital, Harvard Medical School, Boston.
Abstract in Arabic
Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
© 2014 American Academy of Neurology.
Files in this Data Supplement:
- Abstract in Arabic - PDF